Supply Chain Ecosystem Analysis now part of DBMR Reports
Market Size in USD Billion
| 2026 –2033 | |
|
|
USD 4.44 Billion |
| USD 87.72 Billion | |
| % | |
|
North America AI in Bioinformatics Market Segmentation, By Offering (Services, Software, and Others), Type (Machine Learning, Deep Learning, and Others), Product and Services (Bioinformatics Services, Bioinformatics Platforms, and Knowledge Management Tools), Application (Genomics, Chemoinformatics & Drug Design, Proteomics, DNA Sequencing, System Biology, Transcriptomics, Text Mining, Microarrays, Metabolomics, and Others), Sector (Medical Biotechnology, Animal Biotechnology, Plant Biotechnology, Environmental Biotechnology, Forensic Biotechnology, and Others)- Industry Trends and Forecast to 2033
Get Exclusive Sample Copy of this Report Here
|
Attributes
|
North America AI in Bioinformatics Key Market Insights
|
|
Segments Covered
|
|
|
Countries Covered
|
North America
· U.S.
· Canada
· Mexico
|
|
Key Market Players
|
|
|
Market Opportunities
|
· Growing opportunity for AI-driven multi-omics integration platforms that combine genomics, proteomics, and transcriptomics
· Expanding commercial potential in AI-powered drug repurposing solutions
|
|
Value Added Data Infosets
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework
|
“Rising Integration of AI with Genomic and Cloud-Based Bioinformatics Platforms”
Driver
“Rising Demand for Precision Medicine and AI-Enabled Drug Discovery”
Restraint/Challenge
“Data Privacy Risks and High Computational Infrastructure Requirements”
The market is segmented on the basis of offering, type, product and services, application, and sector.
On the basis of offering, the market is segmented into services, software, and others. The software segment dominated the market with the largest revenue share of 52.8% in 2025, driven by the widespread adoption of AI-powered bioinformatics platforms for genomic analysis, drug discovery, and biological data interpretation. Software solutions are increasingly preferred due to their scalability, cloud deployment capabilities, and ability to integrate machine learning models for real-time data processing. Pharmaceutical and biotechnology companies heavily rely on these platforms to accelerate research workflows and reduce operational complexity. In addition, continuous advancements in AI algorithms and user-friendly interfaces are further strengthening software adoption across research institutions and healthcare organizations.
The services segment is expected to witness the fastest growth rate of 20.6% from 2026 to 2033, fueled by rising demand for customized bioinformatics consulting, data analysis services, and managed AI solutions. Many organizations lack in-house expertise to handle complex genomic datasets, increasing reliance on external service providers. Service providers are offering end-to-end support including model development, data interpretation, and cloud integration, making AI adoption easier for smaller biotech firms. Furthermore, the growing trend of outsourcing bioinformatics workflows to specialized vendors is significantly contributing to segment expansion.
On the basis of type, the market is segmented into machine learning, deep learning, and others. The machine learning segment dominated the market with the largest revenue share of 48.5% in 2025, driven by its strong capability in pattern recognition, predictive analytics, and large-scale genomic data processing. Machine learning models are widely used for gene expression analysis, disease prediction, and biomarker identification across biomedical research. Their relatively lower computational complexity compared to deep learning models makes them highly scalable for diverse applications. In addition, continuous improvements in supervised and unsupervised learning techniques are strengthening their adoption in pharmaceutical research and clinical diagnostics.
The deep learning segment is expected to witness the fastest growth rate of 24.1% from 2026 to 2033, driven by its superior performance in analyzing highly complex biological datasets such as protein structures and multi-omics data. Deep learning models, particularly neural networks, are increasingly being used in drug discovery and genomic sequencing interpretation. Their ability to automatically extract features from unstructured biological data is significantly improving research accuracy. Moreover, advancements in high-performance computing infrastructure are enabling wider deployment of deep learning-based bioinformatics solutions across research institutions and biotech companies.
On the basis of product and services, the market is segmented into bioinformatics services, bioinformatics platforms, and knowledge management tools. The bioinformatics platforms segment dominated the market with the largest revenue share of 46.9% in 2025, driven by increasing adoption of integrated AI platforms for genomic sequencing, data visualization, and computational biology workflows. These platforms provide end-to-end solutions that combine data storage, analysis, and interpretation, making them essential for pharmaceutical R&D and academic research. The growing need for centralized, cloud-based systems that support multi-omics data integration is further boosting demand. In addition, continuous platform upgrades with AI-driven automation features are enhancing efficiency and accuracy in biological research.
The knowledge management tools segment is expected to witness the fastest growth rate of 22.3% from 2026 to 2033, driven by increasing need for structured storage and retrieval of vast biological datasets and research insights. These tools help organizations efficiently organize genomic databases, research publications, and experimental results for better decision-making. Rising adoption of AI-powered semantic search and data mining capabilities is improving accessibility of biological knowledge. Furthermore, growing emphasis on collaborative research across biotech firms and academic institutions is accelerating adoption of advanced knowledge management systems.
On the basis of application, the market is segmented into genomics, chemoinformatics & drug design, proteomics, DNA sequencing, system biology, transcriptomics, text mining, microarrays, metabolomics, and others. The genomics segment dominated the market with the largest revenue share of 38.9% in 2025, driven by its extensive use in genetic research, disease diagnosis, and personalized medicine development. AI-powered genomic analysis enables faster identification of genetic mutations and disease-linked biomarkers, significantly improving clinical outcomes. The increasing use of next-generation sequencing data in research and healthcare is further strengthening segment dominance. In addition, continuous advancements in AI algorithms for genome interpretation are enhancing accuracy and scalability in genomic studies.
The chemoinformatics & drug design segment is expected to witness the fastest growth rate of 25.4% from 2026 to 2033, driven by rising demand for AI-assisted drug discovery and molecular modeling. AI tools are increasingly being used to simulate chemical interactions and predict drug efficacy, significantly reducing development timelines. Pharmaceutical companies are adopting these technologies to identify novel drug candidates more efficiently. Moreover, integration of AI with molecular docking and virtual screening is accelerating innovation in early-stage drug development processes.
On the basis of sector, the market is segmented into medical biotechnology, animal biotechnology, plant biotechnology, environmental biotechnology, forensic biotechnology, and others. The medical biotechnology segment dominated the market with the largest revenue share of 57.3% in 2025, driven by extensive use of AI in disease research, precision medicine, and clinical genomics. Healthcare organizations and pharmaceutical companies are increasingly leveraging AI bioinformatics tools to improve diagnostic accuracy and therapeutic development. The rising burden of chronic and genetic diseases is further accelerating adoption in this segment. In addition, strong investment in healthcare innovation and genomic research infrastructure is reinforcing market leadership.
The forensic biotechnology segment is expected to witness the fastest growth rate of 21.9% from 2026 to 2033, driven by increasing use of AI in DNA profiling, criminal investigation, and forensic data analysis. AI-based bioinformatics tools are improving accuracy and speed in identifying genetic evidence from complex biological samples. Law enforcement agencies are increasingly adopting advanced genomic analysis platforms for criminal case resolution. Furthermore, rising demand for automated and highly reliable forensic investigation techniques is supporting rapid segment expansion.
U.S. AI in Bioinformatics Market Insight
The U.S. AI in bioinformatics market captured the largest revenue share of 78.6% in North America in 2025, fueled by the rapid integration of AI-driven genomic sequencing, precision medicine, and drug discovery solutions. Research institutions and biotech companies are increasingly leveraging AI platforms to analyze complex multi-omics data and accelerate biomedical research outcomes. The growing adoption of cloud-based bioinformatics tools and high-performance computing infrastructure further strengthens market expansion. Moreover, strong government funding for genomics initiatives and the presence of major AI and life sciences companies continue to propel market growth.
Canada AI in Bioinformatics Market Insight
The Canada AI in bioinformatics market is projected to expand at a substantial CAGR throughout the forecast period, primarily driven by increasing investments in genomics research and expanding applications of AI in healthcare analytics. The country’s strong academic research ecosystem and government support for biotechnology innovation are encouraging adoption of AI-based bioinformatics platforms. Rising collaborations between universities, research institutes, and biotech firms are further accelerating innovation. In addition, Canada’s focus on personalized medicine and data-driven healthcare solutions is contributing to steady market growth.
Mexico AI in Bioinformatics Market Insight
The Mexico AI in bioinformatics market is expected to grow at a steady CAGR during the forecast period, driven by increasing adoption of digital healthcare technologies and gradual expansion of biotechnology research infrastructure. Rising awareness of precision medicine and growing interest in genomic research are encouraging the use of AI-based bioinformatics tools. The country is also witnessing increased collaboration with international biotech firms and research organizations to strengthen local capabilities. Furthermore, improving healthcare digitalization and expanding cloud computing adoption are supporting the gradual integration of AI in bioinformatics applications across academic and clinical settings.
The North America AI in Bioinformatics industry is primarily led by well-established companies, including:
SKU-
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.